HAO logo

Haoxi Health Technology Limited (HAO) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Haoxi Health Technology Limited (HAO), Communication Services sektöründe faaliyet gösteriyor, son olarak 1.17$'dan işlem görüyor ve 9M piyasa değerine sahip. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 35/100 (ihtiyatlı) olarak derecelendirilmiştir.

Son analiz: 2 Mar 2026
35/100 AI Puanı PD 9M Hacim 18K

Haoxi Health Technology Limited (HAO) Medya ve İletişim Profili

Haoxi Health Technology (HAO) offers a compelling micro-cap opportunity, specializing in online marketing solutions for China's healthcare sector, leveraging short-video platforms and social media to deliver targeted advertising with a remarkably low P/E ratio of 0.89.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 2 Mar 2026

Yatırım Tezi

Haoxi Health Technology presents a notable research candidate due to its strategic focus on the burgeoning Chinese healthcare advertising market and its proficiency in leveraging short-video and social media platforms. With a remarkably low P/E ratio of 0.89, the company appears undervalued relative to its earnings potential. The increasing demand for online healthcare advertising in China, coupled with Haoxi Health's established presence on popular platforms like Douyin and WeChat, positions the company for sustained growth. Key value drivers include expanding its client base within the healthcare sector, enhancing its advertising optimization capabilities, and capitalizing on the increasing adoption of online marketing by healthcare providers in China. The company's focus on short-video marketing aligns with current consumer trends, offering a competitive edge in attracting and engaging target audiences.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market capitalization of $0.01 billion indicates micro-cap status with potential for high growth.
  • P/E ratio of 0.89 suggests the company is undervalued compared to its earnings.
  • Profit margin of 11.8% demonstrates efficient operations and profitability.
  • Gross margin of 2.8% indicates areas for improvement in cost management.
  • Beta of -0.42 suggests the stock is less volatile than the market.

Rakipler & Benzerleri

Güçlü Yönler

  • Specialization in the healthcare industry.
  • Established presence on popular online platforms.
  • Focus on short-video marketing.
  • Low P/E ratio suggests undervaluation.

Zayıflıklar

  • Small market capitalization makes it vulnerable to market fluctuations.
  • Limited geographic diversification (primarily focused on China).
  • Gross margin of 2.8% indicates potential cost management issues.
  • Reliance on a single industry (healthcare).

Katalizörler

  • Upcoming: Potential new partnerships with major healthcare providers in China.
  • Ongoing: Continued growth in the Chinese online healthcare advertising market.
  • Ongoing: Increasing adoption of short-video marketing by healthcare advertisers.

Riskler

  • Potential: Regulatory changes in China impacting online advertising.
  • Potential: Increased competition from larger advertising agencies.
  • Ongoing: Reliance on a single industry (healthcare) makes it vulnerable to sector-specific downturns.
  • Ongoing: Small market capitalization increases volatility and risk of dilution.

Büyüme Fırsatları

  • Expansion into Tier 2 and Tier 3 Cities: Haoxi Health can expand its reach by targeting healthcare advertisers in Tier 2 and Tier 3 cities in China, where the demand for online marketing solutions is growing rapidly. This expansion could significantly increase its client base and revenue streams, tapping into underserved markets with high growth potential. The timeline for this expansion is immediate and ongoing, with a potential market size encompassing millions of potential customers.
  • Diversification of Service Offerings: The company can diversify its service offerings beyond online short video marketing to include other digital marketing services such as search engine optimization (SEO), content marketing, and social media management. This diversification would allow Haoxi Health to provide a more comprehensive suite of solutions to its clients, increasing its value proposition and attracting a wider range of advertisers. The timeline for this diversification is within the next 1-2 years.
  • Strategic Partnerships with Healthcare Providers: Haoxi Health can forge strategic partnerships with healthcare providers, such as hospitals and clinics, to offer integrated marketing solutions that promote their services and attract patients. These partnerships would provide the company with access to a captive audience and enhance its credibility within the healthcare sector. The timeline for establishing these partnerships is within the next year.
  • Leveraging Data Analytics for Targeted Advertising: The company can leverage data analytics to improve the targeting and effectiveness of its online advertising campaigns. By analyzing user data and behavior, Haoxi Health can identify the most relevant audiences for its clients' advertisements, increasing conversion rates and return on investment. The timeline for implementing advanced data analytics is immediate and ongoing.
  • Expansion into Adjacent Healthcare Verticals: Haoxi Health can expand its focus beyond traditional healthcare services to include adjacent verticals such as wellness, fitness, and health technology. This expansion would allow the company to tap into new markets and diversify its revenue streams, capitalizing on the growing consumer interest in health and wellness. The timeline for this expansion is within the next 2-3 years.

Fırsatlar

  • Expansion into Tier 2 and Tier 3 cities in China.
  • Diversification of service offerings.
  • Strategic partnerships with healthcare providers.
  • Leveraging data analytics for targeted advertising.

Tehditler

  • Intense competition in the online advertising market.
  • Changes in regulations governing online advertising in China.
  • Economic slowdown in China could reduce advertising spending.
  • Potential for negative publicity or reputational damage.

Rekabet Avantajları

  • Specialization in the healthcare industry provides industry expertise.
  • Established relationships with key media partners in China.
  • Focus on short-video marketing aligns with current consumer trends.

HAO Hakkında

Founded in 2018 and headquartered in Beijing, China, Haoxi Health Technology Limited operates in the rapidly evolving landscape of online marketing. The company specializes in providing comprehensive online marketing solutions, primarily catering to advertisers within the healthcare industry in China. Haoxi Health's core business revolves around connecting healthcare advertisers with their target audiences through strategic placement and optimization of online advertisements. The company's services include online short video marketing solutions delivered through its media partners, as well as customized marketing solutions encompassing the planning, production, placement, and optimization of online ads. These solutions are designed to help advertisers effectively acquire, convert, and retain consumers across various online media platforms. Haoxi Health strategically utilizes mainstream online short video and social media platforms such as Toutiao, Douyin (the Chinese version of TikTok), WeChat, and Sina Weibo to place its advertisements, ensuring broad reach and targeted engagement. By focusing on the healthcare sector and leveraging popular online platforms, Haoxi Health has carved out a niche in the competitive Chinese advertising market.

Ne Yaparlar

  • Provides online marketing solutions in China.
  • Offers online short video marketing solutions.
  • Offers customized marketing solutions.
  • Plans, produces, places, and optimizes online ads.
  • Helps advertisers acquire, convert, and retain consumers.
  • Places ads through mainstream online short video and social media platforms.
  • Serves advertiser client base primarily in the healthcare industry.

İş Modeli

  • Generates revenue by providing online marketing solutions to advertisers.
  • Earns fees for planning, producing, placing, and optimizing online ads.
  • Partners with media platforms to deliver online short video marketing solutions.

Sektör Bağlamı

Haoxi Health operates within the dynamic Chinese advertising industry, which is experiencing rapid growth driven by increasing internet penetration and the rising popularity of social media and short-video platforms. The healthcare advertising segment is particularly attractive due to the growing demand for online health information and services in China. The competitive landscape includes established advertising agencies and emerging digital marketing firms. Haoxi Health differentiates itself through its specialization in the healthcare sector and its focus on short-video marketing, positioning it to capitalize on the convergence of healthcare and digital media trends.

Kilit Müşteriler

  • Healthcare providers (hospitals, clinics).
  • Pharmaceutical companies.
  • Health and wellness product companies.
AI Güveni: 75% Güncellendi: 2 Mar 2026

Finansallar

Grafik & Bilgi

Haoxi Health Technology Limited (HAO) hisse senedi fiyatı: $1.17 (-0.01, -0.85%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

HAO için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

HAO için Wall Street fiyat hedefi analizi.

MoonshotScore

35/100

Bu puan ne anlama geliyor?

MoonshotScore, HAO'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

HAO Hakkında Sıkça Sorulan Sorular

HAO için değerlendirilmesi gereken temel faktörler nelerdir?

Haoxi Health Technology Limited (HAO) şu anda yapay zeka skoru 35/100, düşük puanı gösteriyor. Hisse 0.9x F/K oranıyla işlem görüyor, S&P 500 ortalamasının (~20-25x) altında, potansiyel değer sinyali. Temel güçlü yan: Specialization in the healthcare industry.. İzlenmesi gereken birincil risk: Potential: Regulatory changes in China impacting online advertising.. Bu bir finansal tavsiye değildir.

HAO MoonshotScore'u nedir?

HAO şu anda MoonshotScore'da 35/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

HAO verileri ne sıklıkla güncellenir?

HAO fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler HAO hakkında ne diyor?

HAO için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

HAO'a yatırım yapmanın riskleri nelerdir?

HAO için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Regulatory changes in China impacting online advertising.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

HAO'ın P/E oranı nedir?

Haoxi Health Technology Limited (HAO)'nın son P/E oranı 0.9, ki bu da piyasa ortalamasının altında, bu da göreli değeri gösterebilir. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.

HAO aşırı değerli mi, yoksa düşük değerli mi?

Haoxi Health Technology Limited (HAO)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 0.9. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

HAO'ın temettü verimi nedir?

Haoxi Health Technology Limited (HAO) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Information is based on available data and may be subject to change.
  • Micro-cap stocks are inherently risky and speculative.
Veri Kaynakları

Popüler Hisseler